NCT00077051View on ClinicalTrials.gov

Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Head and Neck Cancer

Interventions

DRUG

cisplatin

DRUG

cytochlor

DRUG

tetrahydrouridine

RADIATION

radiation therapy

Trial Locations (1)

33136

University of Miami Sylvester Comprehensive Cancer Center, Miami

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Miami

OTHER

NCT00077051 - Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat) | Biotech Hunter | Biotech Hunter